Your browser doesn't support javascript.
loading
Diligent use of MedDRA terminology and preferred term selection in safety reports of clinical trials.
Fey, Martin F; O'Reilly, Seamus; Awada, Ahmad H; Crowley, John; Gelmon, Karen A.
Affiliation
  • Fey MF; Former Chairman of the Department of Medical Oncology, Inselspital and University of Bern, Bern, Switzerland.
  • O'Reilly S; Consultant Medical Oncologist, University College Cork, Cork, Ireland.
  • Awada AH; Medical Oncologist, Institut Jules Bordet, Université Libre de Bruxelles, Bruxelles, Belgium.
  • Crowley J; CRAB Cancer Research and Biostatistics, Seattle, Washington, USA.
  • Gelmon KA; University of British Columbia Faculty of Medicine, 2775 Laurel Street, Vancouver, British Columbia, Canada.
Curr Opin Oncol ; 36(5): 418-420, 2024 Sep 01.
Article in En | MEDLINE | ID: mdl-39106404
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Clinical Trials as Topic / Terminology as Topic Limits: Humans Language: En Journal: Curr Opin Oncol Journal subject: NEOPLASIAS Year: 2024 Type: Article Affiliation country: Switzerland
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Clinical Trials as Topic / Terminology as Topic Limits: Humans Language: En Journal: Curr Opin Oncol Journal subject: NEOPLASIAS Year: 2024 Type: Article Affiliation country: Switzerland